Currently Viewing:
Newsroom
Currently Reading
What We're Reading: DNA Sequencing as Routine Care; HPV Vaccinations and Cervical Cancer; Thirdhand Smoke
May 10, 2018 – AJMC Staff
Phase 1 Trial Will Test Safety of Vaccine for HIV Prevention
April 27, 2018 – Jaime Rosenberg
AJMC® in the Press, April 27, 2018
April 27, 2018 – AJMC Staff
5 Things About Wearable Technology in Healthcare
April 27, 2018 – Laura Joszt
Identification of Genes Involved With MM Development Could Mean More Personalized Treatments
April 16, 2018 – Laura Joszt
Study Recommends DNA Testing to Solve Legionnaires' Disease Outbreaks
April 12, 2018 – Allison Inserro
AJMC® in the Press, March 30, 2018
March 30, 2018 – AJMC Staff
CMS Finalizes Coverage for Next-Generation Sequencing Tests
March 16, 2018 – Jaime Rosenberg
Pembrolizumab Granted Priority Review for Treatment of Cervical Cancer
March 13, 2018 – Jaime Rosenberg

What We're Reading: DNA Sequencing as Routine Care; HPV Vaccinations and Cervical Cancer; Thirdhand Smoke

AJMC Staff
Geisinger Health System will begin to integrate DNA sequencing as part of routine preventive care; a review of evidence confirms that HPV vaccinations protect women against cervical cancer; and new research has found that you may be breathing in tobacco residue in spaces that people haven't smoked in for years.

DNA Sequencing as Routine Care

Geisinger Health System will begin to integrate DNA sequencing as part of preventive care for their patients, reported Modern Healthcare. Within the next 6 months, DNA sequencing will join mammograms and colonoscopies as routine care as the health system enrolls 1000 patients in a pilot program. In 2013, Geisinger launched the MyCode Community Health Initiative, a research-focused genomic initiative that has alerted over 500 patients about their risk of developing early cancer or heart disease. The health system expects 10% to 15% of patients will benefit from the expanded program.



HPV Vaccinations

HPV vaccinations protect women against cervical cancer, especially when they are vaccinated between the ages of 15 and 26 years, researchers have confirmed. The researchers examined evidence from 36 previously published studies including more than 70,000 women and concluded that there are also no serious side effect risks of the vaccine. The new evidence, published in the Cochrane Library, found that for women aged 15 to 26, the vaccine lowered the risk of cervical precancer associated with HPV from 341 to 157 per 10,000.



Thirdhand Smoke

New research has found that you might be breathing in tobacco residue in spaces that no one has smoked in for years. Researchers from Drexel University in Philadelphia have found that chemicals from tobacco smoke left on clothing, furniture, and other surfaces—known as thirdhand smoke—can become airborne and travel through a building’s ventilation system. An aerosol mass spectrometer measurement taken in an indoor classroom showed that the chemicals from thirdhand smoke made up 29% of the air in the room.

Related Articles

How Managed Care Can Advance Responsible Genetic Testing
FDA Takes Step to Reduce Smoking Rates, Proposes Lowering Nicotine Levels in Cigarettes
Dr Anna Beavis Discusses Gender Differences in HPV Vaccination
Dr Anna Beavis Highlights Importance of Addressing Gender Gaps in HPV Vaccination
The Present and Future of Genetic Testing Availability and Spending
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up